Filing Details

Accession Number:
0001179110-17-010741
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-07-27 17:03:15
Reporting Period:
2017-07-25
Filing Date:
2017-07-27
Accepted Time:
2017-07-27 17:03:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1565916 L Hubert Allen 100 Abbott Park Road
Abbott Park IL 60064-6400
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2017-07-25 4,600 $26.70 105,479 No 4 M Direct
Common Shares Without Par Value Disposition 2017-07-25 2,600 $50.80 102,879 No 4 S Direct
Common Shares Without Par Value Disposition 2017-07-25 1,800 $50.79 101,079 No 4 S Direct
Common Shares Without Par Value Disposition 2017-07-25 200 $50.79 100,879 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2017-07-25 4,600 $0.00 4,600 $26.70
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-02-15 2018-02-14 No 4 M Direct
Footnotes
  1. Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.